SOLAND DANIEL B has filed 16 insider transactions across 1 company since June 2021.
Most recent transaction: a option exercise of 9387 shares of ACADIA PHARMACEUTICALS INC ($ACAD) on May 29, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 29, 2025 | ACADIA PHARMACEUTICALS INC | $ACAD | SOLAND DANIEL B | Not found | M | Common Stock | 9387 | $0.00 | 44,041.0000 | 166,362,000 | 27.09% | 0.01% |
| May 29, 2025 | ACADIA PHARMACEUTICALS INC | $ACAD | SOLAND DANIEL B | Not found | M | Restricted Stock Units | 9387 | $0.00 | 0.0000 | 166,362,000 | 100.00% | 0.01% |
| May 29, 2025 | ACADIA PHARMACEUTICALS INC | $ACAD | SOLAND DANIEL B | Not found | A | Director Stock Options (Right to Buy) | 13793 | $0.00 | 13,793.0000 | 166,362,000 | 9999.99% | 0.01% |
| May 29, 2025 | ACADIA PHARMACEUTICALS INC | $ACAD | SOLAND DANIEL B | Not found | A | Restricted Stock Units | 8107 | $0.00 | 8,107.0000 | 166,362,000 | 9999.99% | 0.00% |
| May 29, 2024 | ACADIA PHARMACEUTICALS INC | $ACAD | SOLAND DANIEL B | Not found | M | Common Stock | 6652 | $0.00 | 34,654.0000 | 163,819,000 | 23.76% | 0.00% |
| May 29, 2024 | ACADIA PHARMACEUTICALS INC | $ACAD | SOLAND DANIEL B | Not found | M | Restricted Stock Units | 6652 | $0.00 | 0.0000 | 163,819,000 | 100.00% | 0.00% |
| May 29, 2024 | ACADIA PHARMACEUTICALS INC | $ACAD | SOLAND DANIEL B | Not found | A | Director Stock Options (Right to Buy) | 15959 | $0.00 | 15,959.0000 | 163,819,000 | 9999.99% | 0.01% |
| May 29, 2024 | ACADIA PHARMACEUTICALS INC | $ACAD | SOLAND DANIEL B | Not found | A | Restricted Stock Units | 9387 | $0.00 | 9,387.0000 | 163,819,000 | 9999.99% | 0.01% |
| June 22, 2021 | ACADIA PHARMACEUTICALS INC | $ACAD | SOLAND DANIEL B | Director | M | Common Stock | 3059 | $0.00 | 13,059.0000 | 0 | 30.59% | 0.00% |
| June 7, 2022 | ACADIA PHARMACEUTICALS INC | $ACAD | SOLAND DANIEL B | Director | M | Common Stock | 6391 | $0.00 | 19,450.0000 | 0 | 48.94% | 0.00% |
| June 1, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | SOLAND DANIEL B | Director | M | Common Stock | 8552 | $0.00 | 28,002.0000 | 161,683,000 | 43.97% | 0.01% |
| June 22, 2021 | ACADIA PHARMACEUTICALS INC | $ACAD | SOLAND DANIEL B | Director | M | Restricted Stock Units | 3059 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| June 7, 2022 | ACADIA PHARMACEUTICALS INC | $ACAD | SOLAND DANIEL B | Director | M | Restricted Stock Units | 6391 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| June 1, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | SOLAND DANIEL B | Director | M | Restricted Stock Units | 8552 | $0.00 | 0.0000 | 161,683,000 | 100.00% | 0.01% |
| June 1, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | SOLAND DANIEL B | Director | A | Director Stock Options (Right to Buy) | 11045 | $0.00 | 11,045.0000 | 161,683,000 | 9999.99% | 0.01% |
| June 1, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | SOLAND DANIEL B | Director | A | Restricted Stock Units | 6652 | $0.00 | 6,652.0000 | 161,683,000 | 9999.99% | 0.00% |